Skip to Content

Steris PLC

STE: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$198.00TqkdgBxyvpvyl

Steris Has Steady Fiscal Second Quarter With Cantel Integration Ongoing; Maintain $189 FVE

Narrow-moat Steris’ fiscal second-quarter earnings beat consensus aggregated by FactSet, though results didn't quite meet our higher bar. We are maintaining our $189 fair value estimate. The slightly disappointing results, from our perspective, were offset in our model by time value of money, and some variability in the ongoing integrations of Cantel and Key. Shares still look moderately overvalued to us even after the 4% decline in the stock price on Nov. 3.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of STE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center